Difference between revisions of "Clopidogrel (Plavix)"
m |
m |
||
| Line 1: | Line 1: | ||
==General information== | ==General information== | ||
| − | Class/mechanism: Irreversible thienopyridine class inhibitor of the | + | Class/mechanism: Irreversible thienopyridine class inhibitor of the P2Y<sub>12</sub> class of adenosine diphosphate (ADP) receptors on platelets, inhibiting platelet activation and aggregation.<ref name="insert">[http://products.sanofi.us/PLAVIX/plavix.pdf Clopidogrel (Plavix) package insert]</ref><ref>[[Media:Clopidogrel.pdf | Clopidogrel (Plavix) package insert (locally hosted backup)]]</ref><ref>[http://www.plavix.com Plavix manufacturer's website]</ref> |
<br>Route: PO | <br>Route: PO | ||
<br>Extravasation: n/a | <br>Extravasation: n/a | ||
Revision as of 01:09, 15 August 2017
General information
Class/mechanism: Irreversible thienopyridine class inhibitor of the P2Y12 class of adenosine diphosphate (ADP) receptors on platelets, inhibiting platelet activation and aggregation.[1][2][3]
Route: PO
Extravasation: n/a
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]
Patient drug information
- Clopidogrel (Plavix) manufacturer's patient information[4]
- Clopidogrel (Plavix) package insert PDF pages 7-8[1]
- Clopidogrel (Plavix) patient drug information (UpToDate)[5]
Also known as
Bio-Clopi, Ceruvin, Clop-75, Clopalvix, Clopicard, Clopidro, Clopivas, Lopigrol, Plagril, Stroka